CKD-330 Phase 3 Trial in Amlodipine Non-responder
NCT02586311
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
CKD-330 16/5mg
DRUG:
Amlodipine 5mg Placebo
DRUG:
CKD-330 16/5mg Placebo
DRUG:
Amlodipine 5mg
Sponsor
Chong Kun Dang Pharmaceutical